You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Gynaecological conditions
  5. Uterine prolapse

Urinary incontinence and pelvic organ prolapse in women: management

  • NICE guideline
  • Reference number: NG123
  • Published:  02 April 2019
  • Last updated:  24 June 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendations coming out of this guidance

  • What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women?

  • What is the effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women?

  • What is the effectiveness of ultrasound-guided visualisation compared with clinical assessment to identify complications after mesh surgery for stress urinary incontinence or pelvic organ prolapse in women?

  • What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women?

  • What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women?

  • What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?

  • What is the most effective surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?

  • What is the effectiveness of pain management for women who present with chronic pain 3 months after mesh surgery for stress urinary incontinence or pelvic organ prolapse?

Back to top